Open Access

Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma

  • Authors:
    • Jian Liu
    • Lei Wang
    • Tongqing Wang
    • Jizheng Wang
  • View Affiliations

  • Published online on: July 13, 2018     https://doi.org/10.3892/ol.2018.9145
  • Pages: 4325-4330
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Expression of interleukin-23 receptor (IL-23R) and IL-17 in urinary bladder carcinoma (UBC) was investigated to explore the correlations with prognosis. IL-23/IL-17 axis significantly inhibited the development of inflammatory bowel disease. Thirty patients with UBC were enrolled in Zhengzhou Central Hospital Affiliated to Zhengzhou University from September 2013 to September 2014. Tumor tissue and adjacent healthy tissue were collected, and the levels of IL-23R and IL-17 mRNA were detected by RT-PCR. Thirty healthy people were also selected to serve as normal control group. Serum levels of IL-23R and IL-17 in serum of UBC patients and normal controls were detected by ELISA, and the correlations with clinical features of UBC were analyzed. Pearson's correlation analysis was used to analyze the correlation between IL-23R and IL-17 protein expression. Follow-up study was performed by phone or during patient's visit to out-patient department. Overall survival (OS) and disease-free survival (DFS) curves were plotted by Kaplan-Meier method to analyze the correlation between expression of IL-23R and IL-17 and survival time. ROC curve was used to detect the diagnostic values of IL-23R and IL-17 protein for UBC. Levels of IL-23R and IL-17 mRNA in UBC tissue were 3.26 and 2.65 times higher than those in adjacent tissue (P<0.05), and serum levels of IL-23R and IL-17 protein in UBC patients were significantly higher than those in normal control group. Protein expression levels of IL-23R and IL-17 were correlated with clinical stage and lymph node metastasis in UBC patients (P<0.05), and Cox hazard model showed that L-23R and IL-17 expression may be independent factors for UBC (P<0.05), and high expression levels of IL-23R and IL-17 significantly shortened the OS and DFS (P<0.05). Serum levels of IL-23R and IL-17 can be used to effectively diagnose clinical stage and lymph node metastasis of UBC patients, and the combined diagnosis has a higher sensitivity and specificity than the diagnosis using a single factor. These findings indicated that expression levels of IL-23R and IL-17 were increased in tumor tissue and serum of UBC patients, and the increased expression levels of IL-23R and IL-17 were correlated with poor prognosis. Detection of IL-23R and IL-17 levels has certain clinical significance in the diagnosis and prognosis of UBC.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Wang L, Wang T and Wang J: Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma. Oncol Lett 16: 4325-4330, 2018.
APA
Liu, J., Wang, L., Wang, T., & Wang, J. (2018). Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma. Oncology Letters, 16, 4325-4330. https://doi.org/10.3892/ol.2018.9145
MLA
Liu, J., Wang, L., Wang, T., Wang, J."Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma". Oncology Letters 16.4 (2018): 4325-4330.
Chicago
Liu, J., Wang, L., Wang, T., Wang, J."Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma". Oncology Letters 16, no. 4 (2018): 4325-4330. https://doi.org/10.3892/ol.2018.9145